Search results for "pancrea"

showing 10 items of 814 documents

Survival in patients with primary liver cancer, gallbladder and extrahepatic biliary tract cancer and pancreatic cancer in Europe 1999- 2007: Results…

2015

Abstract Background The EUROCARE study collects and analyses survival data from population-based cancer registries (CRs) in Europe in order to provide data on between-country differences in survival and time trends in survival. Methods This study analyses data on liver cancer, gallbladder and extrahepatic biliary tract cancers (“biliary tract cancers”), and pancreatic cancer diagnosed in 2000–2007 from 88 CRs in 29 countries. Relative survival (RS) was estimated overall, by region, sex, age and period of diagnosis using the complete approach. Time trends in 5-year RS over 1999–2007 were also analysed using the period approach. Results The prognosis of the studied cancers was poor. Age-stand…

Cancer Researchmedicine.medical_specialtySurvivalBiliary tract cancer; Cancer registry; Europe; Pancreatic cancer; Primary liver cancer; Survival; Time trends in survival; Oncology; Cancer ResearchPopulationSocio-culturaleTime trends in survivalGastroenterologyInternal medicinePancreatic cancermedicineeducationSurvival analysiseducation.field_of_studyRelative survivalbusiness.industryGallbladderPrimary liver cancerCancerPancreatic cancerCancer registrymedicine.diseaseCancer registryEuropeBiliary tract cancer ; Cancer registry ; Europe ; Pancreatic cancer ; Primary liver cancer ; Survival ; Time trends in survivalmedicine.anatomical_structureOncologyBiliary tract cancerLiver cancerbusiness
researchProduct

Pancreatic cancer: Wait times from presentation to treatment and survival in a population-based study

2016

Pancreatic survival is one of the worst in oncology. To what extent wait times affect outcomes in unknown No population-based study has previously explored patient and treatment delays among individuals with pancreatic cancer. The aim of this study was to estimate patient and treatment delays in patients with pancreatic cancer and to measure their association with survival in a nonselected population. All patients diagnosed with pancreatic cancer for the first time between 2009 and 2011 and registered in two French digestive cancer registries were included. Patient delay (time from onset of symptoms until the first consultation categorized into <1 or ≥1 month), and treatment delay (time bet…

Cancer Researchmedicine.medical_specialtyeducation.field_of_studybusiness.industryPopulationJaundicemedicine.diseaseComorbidity3. Good healthMetastasisSurgeryCancer registry03 medical and health sciences0302 clinical medicineOncology030220 oncology & carcinogenesisPancreatic cancerInternal medicineEpidemiology of cancerMedicine030211 gastroenterology & hepatologymedicine.symptombusinesseducationSurvival rateInternational Journal of Cancer
researchProduct

In vivo reprogramming for tissue repair.

2015

Berninger and colleagues define milestones for in vivo reprogramming and discuss recent developments in reprogramming into pancreatic b-cells and neurons. Vital organs such as the pancreas and the brain lack the capacity for effective regeneration. To overcome this limitation, an emerging strategy consists of converting resident tissue-specific cells into the cell types that are lost due to disease by a process called in vivo lineage reprogramming. Here we discuss recent breakthroughs in regenerating pancreatic β-cells and neurons from various cell types, and highlight fundamental challenges that need to be overcome for the translation of in vivo lineage reprogramming into therapy.

Cell typeLineage (genetic)Cell- and Tissue-Based TherapyAcinar CellsBiologyIn vivoInsulin-Secreting CellsmedicineHumansRegenerationCell LineagePancreasNeuronsBrain DiseasesRegeneration (biology)BrainPancreatic DiseasesTranslation (biology)Cell DifferentiationCell BiologyTissue repairCellular ReprogrammingCell biologymedicine.anatomical_structurePancreasReprogrammingNeurogliaNature cell biology
researchProduct

Synthesis and pharmacological evaluation of 2'-hydroxychalcones and flavones as inhibitors of inflammatory mediators generation.

1995

2'-Hydroxy-3,4-dimethoxy-3',4'-dimethylchalcone (3a), 2'-hydroxy-3',4',3,4-tetramethoxychalcone (3b), and their corresponding flavones, 3',4'-dimethoxy-7,8-dimethylflavone (4a) and 3',4',7,8-tetramethoxyflavone (4b), were prepared from 3,4-dimethoxycinnamic acid and the respective phenol. The four compounds inhibited enzymic lipid peroxidation and showed weak peroxyl scavenging activity. They also reduced LTB 4 release from human neutrophils stimulated by A23187. The chalcone 3b was the only compound able to inhibit in a concentration-dependent way, synovial human recombinant phospholipase A 2 activity, human platelet TXB 2 generation, and human neutrophil degranulation. This chalcone exert…

ChalconeAntioxidantNeutrophilsmedicine.medical_treatmentFlavonoidChemical synthesisFlavonesCell DegranulationPhospholipases ALipid peroxidationchemistry.chemical_compoundMiceChalconeChalconesDrug DiscoverySynovial FluidmedicineAnimalsHumanschemistry.chemical_classificationFlavonoidsPhospholipase APancreatic ElastaseChemistryDegranulationFree Radical ScavengersPhospholipases A2BiochemistryMolecular MedicineEicosanoidsLipid PeroxidationInflammation MediatorsJournal of medicinal chemistry
researchProduct

Pharmacology of the Sphincter of Oddi

1988

The sphincter of Oddi is the smooth muscle connection between the bile duct and the duodenum. Its physiological function is associated with a regular motility characterized by phasic contractions superimposed on the sphincter of Oddi baseline pressure. Recently introduced ERCP-manometry permits further studies of sphincter of Oddi pharmacology. A number of drugs have so far been studied. Sedatives of the diazepam type had no effect on the sphincter, while butylscopolaminium bromide, a typical neurotropic agent, brings about cessation of the sphincter motility for 3-8 minutes. Hymecromon lowered the sphincter baseline pressure from 9.8 to 7.8 mmHg. A 1.2 mg sublingual dose of nitroglycerin, …

Cholangiopancreatography Endoscopic RetrogradeAmpulla of VaterCommon bile ductManometrybusiness.industryBile ductdigestive oral and skin physiologyGastroenterologyPharmacologydigestive systemSecretinPentazocinemedicine.anatomical_structurePancreatic juiceSphincter of Oddiotorhinolaryngologic diseasesmedicineDuodenumHumansSphincterSphincter of Oddibusinessmedicine.drugEndoscopy
researchProduct

Post-ERCP pancreatitis: A single center experience and an update on prevention strategies

2015

Pancreatitis is the most frequent complication of the ERCP; in unselected patients the incidence is 3.5%, reaching 25%, and is mild-moderate in 90%. A stratification of patients into low or high risk is important to provide adequate information to patients and to decide when refer them to tertiary centers; moreover, many prophylactic measures have been proposed over years. Our aim was to select risk factors for PEP and compare them with current literature in order to propose adequate preventive strategies.It was analyzed the occurrence of Post-ERCP Pancreatitis in a series of 492 consecutives patients treated with ERCP by two expert interventional endoscopists. The possible risk factors wer…

Cholangiopancreatography Endoscopic RetrogradeSettore MED/18 - Chirurgia GeneralePancreatitisRisk FactorsEndoscopic retrograde cholangiopancreatography PancreatitisMultivariate AnalysisContrast MediaHumansCatheterization
researchProduct

ERCP and MRCP--when and why.

2002

Since the introduction of endoscopic retrograde cholangiopancreatography (ERCP) in the 1970s, gastroenterologists have a wide spectrum of diagnostic and therapeutic options in the biliopancreatic ductal system at their disposal. With its arrival in the 1990s, magnetic resonance cholangiopancreatography (MRCP) developed as a potent diagnostic tool in biliopancreatic pathology. Currently, MRCP is widely replacing diagnostic ERCP and thereby avoiding complications related to endoscopic technique.We summarize evidence-based data and demonstrate indications and differential indications for MRCP and ERCP in pancreatic disease. Complications related to the procedures and possible medical preventio…

Cholangiopancreatography Endoscopic Retrogrademedicine.medical_specialtyMagnetic resonance cholangiopancreatographyEndoscopic retrograde cholangiopancreatographyPancreatic diseasemedicine.diagnostic_testbusiness.industryGastroenterologyPancreatic DiseasesInterventional radiologymedicine.diseaseMagnetic Resonance ImagingPancreatic NeoplasmsmedicinePancreatitisHumansInterventional endoscopyRadiologybusinessBest practiceresearch. Clinical gastroenterology
researchProduct

Determination of chromium in treated crayfish,Procambarus clarkii, by Electrothermal AAS: Study of chromium accumulation in different tissues

1986

In the present study, the authors investigated the accumulation of chromium in muscle, hepatopancreas, antennal glands, and gills of Procambarus clarkii (Girard) from Lake Albufera following Cr(VI)-exposure. Determinations of chromium were made by using Electrothermal Atomic Absorption Spectroscopy and the standard additions method.

Chromiuminorganic chemicalsGillChromium CompoundsHealth Toxicology and Mutagenesischemistry.chemical_elementAstacoideaToxicologylaw.inventionChromiumlawAnimalsTissue DistributionProcambarus clarkiibiologySpectrophotometry AtomicGeneral Medicinebiology.organism_classificationCrayfishPollutionKineticschemistryEnvironmental chemistryStandard additionIndicators and ReagentsHepatopancreasAtomic absorption spectroscopyBulletin of Environmental Contamination and Toxicology
researchProduct

Hidden and self-excited attractors in radiophysical and biophysical models

2017

One of the central tasks of investigation of dynamical systems is the problem of analysis of the steady (limiting) behavior of the system after the completion of transient processes, i.e., the problem of localization and analysis of attractors (bounded sets of states of the system to which the system tends after transient processes from close initial states). Transition of the system with initial conditions from the vicinity of stationary state to an attractor corresponds to the case of a self-excited attractor. However, there exist attractors of another type: hidden attractors are attractors with the basin of attraction which does not have intersection with a small neighborhoods of any equ…

Chua circuitskaaosteoriapancreatic beta-cellvirtapiiritattraktoritradiophysical generatoroskillaattoritbiofysiikkaNonlinear Sciences::Chaotic Dynamicshidden attractorsbifurkaatiosäteilyfysiikkamultistabilityself-excited attractorskatastrofiteoriamatemaattiset mallitdifferentiaaliyhtälöt
researchProduct

Diagnostic algorithm for familial chylomicronemia syndrome

2016

International audience; Background: Familial chylomicronemia syndrome (FCS) is a rare genetic disease that leads to severe hypertriglyceridemia often associated with recurrent episodes of pancreatitis. The recognition and correct diagnosis of the disease is challenging due to its rarity, and to the lack of specificity of signs and symptoms. Lipid experts, endocrinologists, gastroenterologists, pancreatologists, and general practitioners may encounter patients who potentially have FCS. Therefore, cooperation between experts and improved knowledge of FCS is essential in improving the diagnosis. Currently, a consensus on best practice for the diagnosis of FCS is lacking. Methods: Aiming to def…

Chylomicrons; Familial chylomicronemia syndrome; Hyperlipoproteinemia; Lipoprotein lipase deficiency; Pancreatitis; Biomarkers; Genetic Markers; Genetic Predisposition to Disease; Humans; Hyperlipoproteinemia Type I; Lipids; Lipoprotein Lipase; Phenotype; Practice Guidelines as Topic; Predictive Value of Tests; Prognosis; Algorithms; Critical Pathways; DNA Mutational Analysis; Decision Support Techniques; Mutation; Internal Medicine; Cardiology and Cardiovascular MedicineSettore MED/09 - Medicina InternaACUTE-PANCREATITIS[SDV]Life Sciences [q-bio]DNA Mutational AnalysisPredictive Value of TestDisease030204 cardiovascular system & hematologyVARIANTSDecision Support Technique0302 clinical medicineDOMAINGenetic MarkerBINDINGChylomicronsHYPERTRIGLYCERIDEMICMedicine030212 general & internal medicinePANCREATITISLipoprotein lipase deficiencyGeneral MedicineFamilial ChylomicronemiaLipidPrognosisLipids3. Good healthAlgorithmDEFICIENCYPhenotypeCritical PathwayPractice Guidelines as TopicCritical PathwaysHyperlipoproteinemia Type Ilipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicineAlgorithmAlgorithmsHumanGenetic MarkersSevere hypertriglyceridemiaFamilial chylomicronemia syndromePrognosiSigns and symptomsLIPOPROTEIN-LIPASEHyperlipoproteinemiaCLASSIFICATIONDecision Support TechniquesSecondary careChylomicronDNA Mutational Analysi03 medical and health sciencesPredictive Value of TestsInternal MedicineMANAGEMENTHumansGenetic Predisposition to DiseasePancreatitibusiness.industryBiomarkerLipoprotein LipaseMutationbusinessBiomarkers
researchProduct